| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5845611 | Pulmonary Pharmacology & Therapeutics | 2015 | 8 Pages |
Abstract
Treatment selection according to patient's symptoms as well as lung function is an important consideration in maintenance treatment of COPD. Indacaterol 150 and 300 μg effectively improved lung function and symptoms in patients across all GOLD 2011 categories.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Huib A.M. Kerstjens, Gaëtan Deslée, Ronald Dahl, James F. Donohue, David Young, David Lawrence, Oliver Kornmann,